Upcoming events – Obseva's first fibroid foray and Newron's test in Retts

Upcoming events – Obseva's first fibroid foray and Newron's test in Retts

Source: 
EP Vantage
snippet: 

Welcome to your weekly roundup of approaching clinical readouts. In the fourth quarter Obseva will see data from the first of two phase III trials of its gonadotropin-releasing hormone (GnRH) antagonist linzagolix in uterine fibroids.